White-bagging policies like Aetna’s present a number of issues for providers including decreased net revenue, increased cost associated with storing and preparing white-bag drugs, as well as increased statutory and regulatory compliance risk.
Read MoreHow Aetna’s “white-bagged” drug policies are putting your patients and your reimbursement at risk
Posted on
